Gene · 5451
Papers3,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated level of lysophosphatidic acid among patients with HNF1B mutations and its role in RCAD syndrome: a multiomic study. | Metabolomics | 2022 | 35179657 | PubTator, text mining | PubMed |
| MicroRNA let-7 and viral infections: focus on mechanisms of action. | Cell Mol Biol Lett | 2022 | 35164678 | PubTator, text mining | PubMed |
| Mechanistic Basis for the Role of Phytochemicals in Inflammation-Associated Chronic Diseases. | Molecules | 2022 | 35164043 | PubTator, text mining | PubMed |
| Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins. | Int J Mol Sci | 2022 | 35163748 | PubTator, text mining | PubMed |
| Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology. | Int J Mol Sci | 2022 | 35163583 | PubTator, text mining | PubMed |
| Clinical and Nonclinical Disposition and In Vitro Drug-Drug Interaction Potential of Felcisetrag, a Highly Selective and Potent 5-HT4 Receptor Agonist. | Eur J Drug Metab Pharmacokinet | 2022 | 35157234 | PubTator, text mining | PubMed |
| Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration. | Cancer Cell Int | 2022 | 35151325 | PubTator, text mining | PubMed |
| Recent insights into the use of immune checkpoint inhibitors in gastric cancer. | Porto Biomed J | 2022 | 35146175 | PubTator, text mining | PubMed |
| NBMA Promotes Spermatogenesis by Mediating Oct4 Pathway. | ChemistryOpen | 2022 | 35142088 | PubTator, text mining | PubMed |
| Human transcription factor protein interaction networks. | Nat Commun | 2022 | 35140242 | PubTator, text mining | PubMed |
| Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives. | J Exp Clin Cancer Res | 2022 | 35135603 | PubTator, text mining | PubMed |
| The wide and growing range of lamin B-related diseases: from laminopathies to cancer. | Cell Mol Life Sci | 2022 | 35132494 | PubTator, text mining | PubMed |
| Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review. | Mol Cell Biochem | 2022 | 35129779 | PubTator, text mining | PubMed |
| Genetic Diversity of HPV 16 and HPV 18 Based on Partial Long Control Region in Iranian Women. | Can J Infect Dis Med Microbiol | 2022 | 35126798 | PubTator, text mining | PubMed |
| Novel Insights into the Emerging Role of Neat1 and Its Effects Downstream in the Regulation of Inflammation. | J Inflamm Res | 2022 | 35115805 | PubTator, text mining | PubMed |
| Manipulation of RNA polymerase III by Herpes Simplex Virus-1. | Nat Commun | 2022 | 35110532 | PubTator, text mining | PubMed |
| Specific Regulatory Motifs Network in SARS-CoV-2-Infected Caco-2 Cell Line, as a Model of Gastrointestinal Infections. | Cell Reprogram | 2022 | 35100036 | PubTator, text mining | PubMed |
| Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer. | J Oncol | 2022 | 35087589 | PubTator, text mining | PubMed |
| The regulation of PBXs and their emerging role in cancer. | J Cell Mol Med | 2022 | 35068042 | PubTator, text mining | PubMed |
| rs9390123 and rs9399451 influence the DNA repair capacity of lung cancer by regulating PEX3 and PHACTR2‑AS1 expression instead of PHACTR2. | Oncol Rep | 2022 | 35059740 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5451/papers?page=25